Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- history of soil exposure in an endemic area
- infection with other parasites
Outros fatores diagnósticos
- abdominal pain
- altered bowel habit
- weight loss
- fever (hyperinfection)
- signs of sepsis (hyperinfection)
- chronic cough
- wheezing
- pruritus or dermatitis
- larva currens
- urticaria
- cutaneous larva migrans
- apparent drug reaction rash (hyperinfection)
- other skin complaints
- symptoms and signs of inflammatory bowel disease
- signs of neurologic manifestations
Fatores de risco
- soil exposure in endemic region or migrantion from an endemic region
- corticosteroid use (risk of hyperinfection)
- human T-cell lymphotropic virus type-1 (HTLV-1) infection (risk of hyperinfection)
- international travelers
- impaired immunity
- solid-organ transplant recipient
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- stool ova and parasites (O&P) exam
- CBC with differential
- therapeutic trial of ivermectin (in specific situations)
Investigações a serem consideradas
- sputum O&P exam
- clinical sample (nonstool or sputum) O&P exam
- strongyloides IgG serology
- tissue biopsy
Novos exames
- polymerase chain reaction (PCR)
- strongyloides IgG4 urine
Algoritmo de tratamento
immigrant from endemic area
able to tolerate oral therapy: not critically ill (nonpregnant)
unable to tolerate oral therapy or critically ill (nonpregnant)
pregnant
poor clinical response or initial treatment not completed
Colaboradores
Autores
Louis M. Weiss , MD, MPH
Professor, Department of Pathology
Professor, Department of Medicine (Infectious Diseases)
Albert Einstein College of Medicine
Bronx, NY
Declarações
LMW has received grant funding from the National Institute of Health for research on Toxoplasma gondii and microsporidiosis. LMW receives training grants for infectious diseases at the Albert Einstein College of Medicine, and serves on the board of the Humane Society of Westchester.
Agradecimentos
Dr Louis M. Weiss would like to gratefully acknowledge Dr David R. Boulware, the previous contributor to this topic. DRB declares that he has no competing interests.
Revisores
Elizabeth Barnett, MD
Professor
Department of Pediatrics
Boston Medical Center
Boston University
Boston, MA
Declarações
EB declares that she is on a speaker's bureau for Merck.
Linda Nield, MD, FAAP
Professor of Pediatrics
West Virginia University School of Medicine
Morgantown, WV
Declarações
LN declares that she has no competing interests.
Geoff Gill, MA, MSc, MD, FRCP, DTMH
Professor of International Medicine and Honorary Consultant Physician
Liverpool School of Tropical Medicine
Liverpool
UK
Declarações
GG declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
World Gastroenterology Organisation. WGO practice guideline: management of strongyloidiasis. February 2018 [internet publication].Texto completo
Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Hookworm
- Schistosomiasis
- Filariasis
Mais Diagnósticos diferenciaisDiretrizes
- Clinical care of strongyloides
- WGO practice guideline: management of strongyloidiasis
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal